Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoogervorst, E. M.
Right arrow Articles by van Steeg, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoogervorst, E. M.
Right arrow Articles by van Steeg, H.
[Cancer Research 64, 5118-5126, August 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

p53 Heterozygosity Results in an Increased 2-Acetylaminofluorene-Induced Urinary Bladder but not Liver Tumor Response in DNA Repair-Deficient Xpa Mice

Esther M. Hoogervorst1,2, Conny Th. M. van Oostrom1, Rudolf B. Beems1, Jan van Benthem1, Siska Gielis1, Jolanda P. Vermeulen1, Piet W. Wester1, Joseph G. Vos1,2, Annemieke de Vries1 and Harry van Steeg1

1 National Institute of Public Health and the Environment, Laboratory of Toxicology, Pathology and Genetics, Bilthoven, and 2 Utrecht University, Department of Pathobiology, Utrecht, the Netherlands

Both nucleotide excision repair (NER) and the p53 tumor suppressor protein play crucial roles in the prevention of cells becoming cancerous. This is clearly demonstrated by the fact that NER-deficient xeroderma pigmentosum patients and Li-Fraumeni patients who carry a germ-line p53 mutation are highly tumor prone. The NER-deficient Xpa and the p53+/– mouse models clearly mimic their human counterparts, because they are both tumor prone as well. The aim of the study presented here was to analyze the relative contribution of these two pathways in tumor suppression and to analyze a possible link between NER and p53 activation in vivo. For this, we exposed Xpa, p53+/–, and Xpa/p53+/– mice to 2-acetylaminofluorene (2-AAF). We show that 2-AAF-induced urinary bladder tumor suppression is dependent on p53 status, because p53+/– mice were highly tumor prone. Xpa/p53+/– mice were even more tumor prone, whereas no increased tumor response was found in Xpa mice. Short-term assays revealed a decreased apoptotic response in Xpa/p53+/– mice, pointing in vivo toward a link between NER and p53-mediated apoptosis. In contrast, liver tumor response was primarily dependent on appropriate DNA repair, because Xpa-deficient mice were liver tumor prone. p53 heterozygosity had no influence on liver tumor incidences, in line with the results obtained from the short-term 2-AAF studies revealing no altered cellular response in p53+/– or Xpa/p53+/– mice. Interestingly, however, mice completely deficient in both NER and p53 (Xpa/p53–/– mice) showed a dramatic increase of hepatocellular proliferation accompanied by lacZ reporter gene mutations.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
W. Bruins, M. J. Jonker, O. Bruning, J. L.A. Pennings, M. M. Schaap, E. M. Hoogervorst, H. van Steeg, T. M. Breit, and A. de Vries
Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation
Carcinogenesis, August 1, 2007; 28(8): 1814 - 1823.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. W.P. Wijnhoven, E. N. Speksnijder, X. Liu, E. Zwart, C. Th. M. vanOostrom, R. B. Beems, E. M. Hoogervorst, M. M. Schaap, L. D. Attardi, T. Jacks, et al.
Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage
Cancer Res., May 15, 2007; 67(10): 4648 - 4656.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. W.P. Wijnhoven, E. Zwart, E. N. Speksnijder, R. B. Beems, K. P. Olive, D. A. Tuveson, J. Jonkers, M. M. Schaap, J. van den Berg, T. Jacks, et al.
Mice Expressing a Mammary Gland-Specific R270H Mutation in the p53 Tumor Suppressor Gene Mimic Human Breast Cancer Development
Cancer Res., September 15, 2005; 65(18): 8166 - 8173.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. Hoogervorst, W. Bruins, E. Zwart, C. Th.M. van Oostrom, G. J. van den Aardweg, R. B. Beems, J. van den Berg, T. Jacks, H. van Steeg, and A. de Vries
Lack of p53 Ser389 Phosphorylation Predisposes Mice to Develop 2-Acetylaminofluorene-Induced Bladder Tumors but not Ionizing Radiation-Induced Lymphomas
Cancer Res., May 1, 2005; 65(9): 3610 - 3616.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.